Previous close | 10.00 |
Open | 10.00 |
Bid | 9.20 |
Ask | 12.10 |
Strike | 75.00 |
Expiry date | 2024-07-19 |
Day's range | 10.00 - 10.00 |
Contract range | N/A |
Volume | |
Open interest | 138 |
Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
Veracyte's (VCYT) first-quarter 2024 performance reflects the strength of its testing business.